X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (59658) 59658
Newspaper Article (385) 385
Newsletter (252) 252
Book Chapter (224) 224
Magazine Article (86) 86
Dissertation (28) 28
Book / eBook (25) 25
Conference Proceeding (22) 22
Publication (15) 15
Book Review (12) 12
Web Resource (10) 10
Trade Publication Article (7) 7
Reference (6) 6
Streaming Video (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (45002) 45002
male (23478) 23478
platelet aggregation - drug effects (21111) 21111
female (18499) 18499
animals (16797) 16797
middle aged (13100) 13100
blood platelets - drug effects (11274) 11274
platelet aggregation inhibitors - therapeutic use (11218) 11218
aged (10545) 10545
adult (9339) 9339
hematology (8599) 8599
platelet aggregation inhibitors - pharmacology (8343) 8343
blood platelets - metabolism (7478) 7478
aspirin (7046) 7046
cardiac & cardiovascular systems (6936) 6936
peripheral vascular disease (6754) 6754
platelets (6509) 6509
platelet aggregation (6349) 6349
blood platelets (6060) 6060
pharmacology & pharmacy (5938) 5938
ticlopidine - analogs & derivatives (5695) 5695
treatment outcome (5686) 5686
clopidogrel (5566) 5566
platelet aggregation inhibitors - adverse effects (5556) 5556
platelet aggregation inhibitors - administration & dosage (5554) 5554
risk factors (5523) 5523
aggregation (5495) 5495
thrombosis (5380) 5380
in vitro techniques (5172) 5172
rats (5126) 5126
time factors (4944) 4944
adenosine diphosphate - pharmacology (4636) 4636
aspirin - therapeutic use (4632) 4632
dose-response relationship, drug (4470) 4470
blood platelets - physiology (4120) 4120
activation (3717) 3717
drug therapy, combination (3581) 3581
rabbits (3364) 3364
mice (3335) 3335
ticlopidine - therapeutic use (3310) 3310
aspirin - pharmacology (3298) 3298
platelet activation - drug effects (3160) 3160
percutaneous coronary intervention (2938) 2938
risk (2938) 2938
inhibition (2934) 2934
analysis (2868) 2868
aspirin - administration & dosage (2781) 2781
biochemistry & molecular biology (2764) 2764
collagen - pharmacology (2764) 2764
aged, 80 and over (2737) 2737
platelet-aggregation (2718) 2718
stroke (2689) 2689
care and treatment (2667) 2667
myocardial-infarction (2513) 2513
surgery (2505) 2505
abridged index medicus (2504) 2504
prospective studies (2495) 2495
drug therapy (2468) 2468
medicine, general & internal (2468) 2468
therapy (2462) 2462
anticoagulants - therapeutic use (2445) 2445
research (2415) 2415
prevention (2411) 2411
mortality (2400) 2400
platelet activation (2387) 2387
acute coronary syndromes (2340) 2340
stents (2321) 2321
blood coagulation - drug effects (2301) 2301
cell biology (2272) 2272
anticoagulants (2258) 2258
cardiovascular disease (2257) 2257
thrombin - pharmacology (2219) 2219
platelet (2183) 2183
platelet adhesiveness - drug effects (2172) 2172
antiplatelet therapy (2168) 2168
heart attacks (2165) 2165
thrombin (2161) 2161
cardiology (2155) 2155
blood (2107) 2107
disease (2076) 2076
aspirin - adverse effects (2062) 2062
hemorrhage - chemically induced (2053) 2053
medicine & public health (2030) 2030
health aspects (2004) 2004
ticlopidine - administration & dosage (1991) 1991
thrombosis - prevention & control (1976) 1976
cardiovascular (1961) 1961
ticlopidine - adverse effects (1956) 1956
inflammation (1942) 1942
platelet count (1933) 1933
platelet function tests (1893) 1893
retrospective studies (1863) 1863
platelet glycoprotein gpiib-iiia complex - antagonists & inhibitors (1819) 1819
collagen (1816) 1816
atherosclerosis (1808) 1808
double-blind method (1727) 1727
coronary heart disease (1716) 1716
risk assessment (1714) 1714
cells, cultured (1702) 1702
cardiovascular diseases (1693) 1693
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (56756) 56756
German (974) 974
Russian (923) 923
Japanese (873) 873
French (514) 514
Chinese (501) 501
Italian (331) 331
Spanish (312) 312
Polish (157) 157
Czech (59) 59
Dutch (44) 44
Danish (43) 43
Portuguese (43) 43
Hungarian (28) 28
Swedish (26) 26
Ukrainian (26) 26
Turkish (25) 25
Norwegian (19) 19
Romanian (15) 15
Slovak (15) 15
Croatian (12) 12
Serbian (12) 12
Finnish (10) 10
Hebrew (9) 9
Bulgarian (7) 7
Korean (7) 7
Lithuanian (6) 6
Bosnian (1) 1
Greek (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of clinical investigation, ISSN 0021-9738, 2006, Volume 116, Issue 12, pp. 3211 - 3219
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2008, Volume 359, Issue 12, pp. 1238 - 1251
In this large clinical trial, aspirin plus extended-release dipyridamole was found to have an efficacy similar to that of clopidogrel in the prevention of... 
ACTIVE CONTROLLED-TRIALS | HIGH-RISK PATIENTS | TICLOPIDINE | TRANSIENT ISCHEMIC ATTACK | DOUBLE-BLIND | PREVENTION | RANDOMIZED CONTROLLED-TRIAL | ARTERIAL ORIGIN ESPRIT | CEREBRAL-ISCHEMIA | UMCG Approved | NON-INFERIORITY TRIALS | ISSUES | MEDICINE, GENERAL & INTERNAL | PLACEBO | DESIGN | WARFARIN | REGIMENS | Myocardial Infarction - epidemiology | Benzoates - therapeutic use | Ticlopidine - therapeutic use | Humans | Middle Aged | Male | Risk | Secondary Prevention | Aspirin - administration & dosage | Vascular Diseases - mortality | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Dipyridamole - adverse effects | Female | Stroke - epidemiology | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Dipyridamole - therapeutic use | Benzimidazoles - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Brain Ischemia - epidemiology | Stroke - prevention & control | Double-Blind Method | Kaplan-Meier Estimate | Proportional Hazards Models | Brain Ischemia - prevention & control | Factor Analysis, Statistical | Stroke - drug therapy | Ticlopidine - analogs & derivatives | Aged | Hemorrhage - chemically induced | Delayed-Action Preparations | Stroke (Disease) | Aspirin | Usage | Care and treatment | Dipyridamole | Clopidogrel | Health aspects | Stroke | Index Medicus | Abridged Index Medicus | Recurrence | Brain Ischemia | Benzimidazoles | Follow-Up Studies | Neurons and Cognition | Cognition | Hemorrhage | Drug Delivery Systems | Life Sciences | Angiotensin II Type 1 Receptor Blockers | Angiotensin-Converting Enzyme Inhibitors | Vascular Diseases | Mental Status Schedule | Retrospective Studies | Severity of Illness Index | Disability Evaluation | Benzoates | Drug Administration Schedule | International Cooperation | Ticlopidine | Myocardial Infarction | Platelet Aggregation Inhibitors | Santé publique et épidémiologie | Original | Dipyridamole/adverse effects/therapeutic use | Angiotensin-Converting Enzyme Inhibitors/therapeutic use | Recurrence/prevention & control | Benzoates/therapeutic use | Brain Ischemia/epidemiology/prevention & control | MEDICIN OCH HÄLSOVETENSKAP | Platelet Aggregation Inhibitors/administration & dosage/adverse | Combination | MEDICAL AND HEALTH SCIENCES | Aspirin/administration & dosage/adverse effects | Myocardial Infarction/epidemiology | Factor Analysis | Benzimidazoles/therapeutic use | Drug Therapy | Ticlopidine/adverse effects/analogs & derivatives/therapeutic use | effects/therapeutic use | Vascular Diseases/mortality | Hemorrhage/chemically induced | Stroke/drug therapy/epidemiology/prevention & control | Statistical | Kaplan-Meiers Estimate
Journal Article
British journal of pharmacology, ISSN 1476-5381, 2005, Volume 146, Issue 6, pp. 882 - 893
Journal Article
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2009, Volume 53, Issue 10, pp. 849 - 856
...) correlates with the risk of early drug-eluting stent thrombosis (ST). Background Studies using light transmission aggregometry (LTA... 
Cardiovascular | Internal Medicine | clopidogrel | whole blood aggregometry | stent thrombosis | platelet aggregation | ADVERSE CARDIOVASCULAR EVENTS | PERCUTANEOUS CORONARY INTERVENTION | RESPONSIVENESS | CARDIAC & CARDIOVASCULAR SYSTEMS | INHIBITION | IMPLANTATION | PREDICTORS | RESISTANCE | BARE-METAL | ANTAGONISTS | AGGREGOMETRY | Prospective Studies | Platelet Function Tests - methods | Ticlopidine - pharmacology | Ticlopidine - therapeutic use | Humans | Kaplan-Meier Estimate | Male | Thrombosis - epidemiology | Coronary Artery Disease - mortality | Electric Impedance | Ticlopidine - analogs & derivatives | Drug-Eluting Stents - adverse effects | Electrodes | Coronary Artery Disease - therapy | Point-of-Care Systems | Thrombosis - etiology | Ticlopidine - adverse effects | Platelet Aggregation Inhibitors - pharmacology | Female | Platelet Function Tests - instrumentation | Aged | Platelet Aggregation - drug effects | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Transluminal angioplasty | Coenzymes | Vasodilators | Adenosine diphosphate | Coronary heart disease | Thrombosis | Stent (Surgery) | Blood clot | Aggregation | Disease transmission | Blood platelets | Analysis | Adenosine triphosphatase | Drug therapy | Intervention | Anticoagulants | Aspirin | Heart attacks | Medical imaging | Cardiovascular disease | Studies | Confidence intervals | Coronary vessels | Acute coronary syndromes | Stents | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2009, Volume 374, Issue 9694, pp. 989 - 997
.... Methods In the PRINCIPLE-TIMI 44 trial, the primary outcome was inhibition of platelet aggregation at 6 h assessed by light-transmission aggregometry... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | THERAPY | PLATELET-AGGREGATION | OF-FUNCTION POLYMORPHISM | OMEPRAZOLE | THROMBOLYSIS | ACUTE CORONARY SYNDROMES | OUTCOMES | ANTIPLATELET ACTION | ATORVASTATIN | Multivariate Analysis | Prasugrel Hydrochloride | Thiophenes - therapeutic use | Thiophenes - adverse effects | Ticlopidine - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Pyridines - adverse effects | Drug Interactions | Ticlopidine - adverse effects | Cardiovascular Diseases - epidemiology | Female | Platelet Aggregation - drug effects | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Pyridines - therapeutic use | Proton Pump Inhibitors - adverse effects | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Logistic Models | Treatment Outcome | Piperazines - therapeutic use | Proton Pump Inhibitors - therapeutic use | Piperazines - adverse effects | Ticlopidine - analogs & derivatives | Randomized Controlled Trials as Topic | Acute Coronary Syndrome - drug therapy | Aged | Complications and side effects | Clopidogrel | Proton pump inhibitors | Dosage and administration | Pharmacology | Research | Properties | Studies | Data collection | Data analysis | Drug therapy | Acute coronary syndromes | Clinical outcomes | Cytochrome | Myocardial infarction | Cerebral infarction | Stroke | Funding | Clinical trials | Platelet aggregation | Agglomeration | Patients | Evidence-based medicine | Randomization | Blood platelets | Infarction | Inhibition | Index Medicus | Abridged Index Medicus
Journal Article
Circulation, ISSN 0009-7322, 06/2007, Volume 115, Issue 25, pp. 3156 - 3164
Journal Article
Journal Article